Novo Nordisk Warns About Counterfeit Ozempic

Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain in the United States. The country’s health regulator seized the counterfeit injections on April 9 and is…

Read Full Article (External Site)